Suchergebnisse - "Kang, J"

PubPharm (30)

1

Correction : The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion

enthalten in: Oncogene | 2019

von Jeong, K. | Park, S. | Cho, K. | +7

ErratumFor: Oncogene. 2012 Sep 27;31(39):4279-89. - PMID 22249252

2

Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer

enthalten in: Oncogene | 2018

von Song, S. | Jeon, M. | Nam, J. | +7

3

TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation

enthalten in: Oncogene | 2017

von Kang, J. | Kim, W. | Lee, S. | +7

4

Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression

enthalten in: Oncogene | 2015

von Kang, J. | Song, S. | Yun, J. | +4

5

PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling

enthalten in: Oncogene | 2014

von Yun, S. | Yoon, K. | Lee, S. | +12

6

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

enthalten in: Oncogene | 2013

von Eberlein, C. | Kendrew, J. | McDaid, K. | +15

7

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

enthalten in: Oncogene | 2013

von Eberlein, C. | Kendrew, J. | McDaid, K. | +15

8

SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment

enthalten in: Oncogene | 2013

von Hong, S. | Lee, S. | Moon, J. | +19

9

SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment

enthalten in: Oncogene | 2013

von Hong, S. | Lee, S. | Moon, J. | +19

10

CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling

enthalten in: Oncogene | 2012

von Kang, J. | Park, S. | Kim, S. | +4